Format

Send to

Choose Destination
Hum Mutat. 2017 Feb;38(2):204-215. doi: 10.1002/humu.23147. Epub 2016 Dec 5.

A Cell Type-Specific Expression Signature Predicts Haploinsufficient Autism-Susceptibility Genes.

Zhang C1,2,3, Shen Y1,4,5.

Author information

1
Department of Systems Biology, Columbia University, New York, New York.
2
Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York.
3
Center for Motor Neuron Biology and Disease, Columbia University, New York, New York.
4
Department of Biomedical Informatics, Columbia University, New York, New York.
5
JP Sulzberger Genome Center, Columbia University, New York, New York.

Abstract

Recent studies have identified many genes with rare de novo mutations in autism, but a limited number of these have been conclusively established as disease-susceptibility genes due to the lack of recurrence and confounding background mutations. Such extreme genetic heterogeneity severely limits recurrence-based statistical power even in studies with a large sample size. Here, we use cell-type specific expression profiles to differentiate mutations in autism patients from those in unaffected siblings. We report a gene expression signature in different neuronal cell types shared by genes with likely gene-disrupting (LGD) mutations in autism cases. This signature reflects haploinsufficiency of risk genes enriched in transcriptional and post-transcriptional regulators, with the strongest positive associations with specific types of neurons in different brain regions, including cortical neurons, cerebellar granule cells, and striatal medium spiny neurons. When used to prioritize genes with a single LGD mutation in cases, a D-score derived from the signature achieved a precision of 40% as compared with the 15% baseline with a minimal loss in sensitivity. An ensemble model combining D-score with mutation intolerance metrics from Exome Aggregation Consortium further improved the precision to 60%, resulting in 117 high-priority candidates. These prioritized lists can facilitate identification of additional autism-susceptibility genes.

KEYWORDS:

D-score; autism spectrum disorders; autism-susceptibility genes; cell type-specific expression signature; de novo mutations

PMID:
27860035
PMCID:
PMC5865588
DOI:
10.1002/humu.23147
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center